Skip to Main Content

Author Details

Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
1983
732
117
PMIDPaper TitleJournal TitlePublished Year
37090539Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival.medRxiv2024
34583947Molecular characterisation of pancreatic ductal adenocarcinoma with <i>NTRK</i> fusions and review of the literature.J Clin Pathol2023
38028629Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC).Front Genet2023
37525960hENT1 as a Predictive Biomarker in PDAC-Response.Clin Cancer Res2023
37754493<i>Helicobacter pylori</i> Status May Differentiate Two Distinct Pathways of Gastric Adenocarcinoma Carcinogenesis.Curr Oncol2023
37558751Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers.NPJ Precis Oncol2023
37746604Call to Improve the Quality of Prediction Tools for Intrahepatic Cholangiocarcinoma Resection: A Critical Appraisal, Systematic Review, and External Validation Study.Ann Surg Open2023
37656784BRAF<sup>οβ3-αC</sup> in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggability.Sci Adv2023
37847995Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group.J Clin Oncol2023
37787975Deciphering the Pathways to PARP Sensitivity in Pancreatic Cancer.Clin Cancer Res2023
37544360A Highly Sensitive Pan-Cancer Test for Microsatellite Instability.J Mol Diagn2023
37768107Hourglass, a rapid analysis framework for heterogeneous bioimaging data, identifies sex disparity in IL-6/STAT3-associated immune phenotypes in pancreatic cancer.J Pathol2023
37351909Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization.Cancer Epidemiol Biomarkers Prev2023
36949200RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer.Nature2023
37249599A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk.Cancer Res2023
37449843Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical Setting.Cancer Discov2023
37181409Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database.EClinicalMedicine2023
37365285Probing the diabetes and colorectal cancer relationship using gene - environment interaction analyses.Br J Cancer2023
37130158Toronto Management of Initially Unresectable Liver Metastasis from Colorectal Cancer in a Living Donor Liver Transplant Program.J Am Coll Surg2023
36964717Evaluating colonoscopy screening intervals in patients with Lynch syndrome from a large Canadian registry.J Natl Cancer Inst2023
36622766Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort.Cancer Epidemiol Biomarkers Prev2023
36445035Body mass index and molecular subtypes of colorectal cancer.J Natl Cancer Inst2023
36782065Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries.Nat Genet2023
36648535Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases.J Gastroenterol2023
36915452Whole-genome sequencing of 20 cholangiocarcinoma cases reveals unique profiles in patients with cirrhosis and primary sclerosing cholangitis.J Gastrointest Oncol2023
36847955ASO Visual Abstract: Optimizing Circulating Tumor DNA Use in the Perioperative Setting for Intrahepatic Cholangiocarcinoma-Diagnosis, Screening, Minimal Residual Disease Detection, and Treatment Response Monitoring.Ann Surg Oncol2023
36808320Optimizing Circulating Tumour DNA Use in the Perioperative Setting for Intrahepatic Cholangiocarcinoma: Diagnosis, Screening, Minimal Residual Disease Detection and Treatment Response Monitoring.Ann Surg Oncol2023
36396080Evaluating Multiple Next-Generation Sequencing-Derived Tumor Features to Accurately Predict DNA Mismatch Repair Status.J Mol Diagn2023
36576985Genome-wide Interaction Study with Smoking for Colorectal Cancer Risk Identifies Novel Genetic Loci Related to Tumor Suppression, Inflammation, and Immune Response.Cancer Epidemiol Biomarkers Prev2023
36539618Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries.Nat Genet2023
36804209Preoperative neutrophil-to-lymphocyte ratio is prognostic for early recurrence after curative intrahepatic cholangiocarcinoma resection.Ann Hepatobiliary Pancreat Surg2023
36707929Molecular Characteristics of Early-Onset Colorectal Cancer According to Detailed Anatomical Locations: Comparison With Later-Onset Cases.Am J Gastroenterol2023
36929942Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions.J Natl Cancer Inst2023
36927977Systemic inflammatory prognostic scores in advanced pancreatic adenocarcinoma.Br J Cancer2023
36171645DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancer.J Natl Cancer Inst2023
36350458Health-Related Quality of Life Following Simultaneous Resection for Synchronous Colorectal Cancer Liver Metastases.Ann Surg Oncol2023
34176743PATCH-DP: a single-arm phase II trial of intra-operative application of HEMOPATCHâ¿¢ to the pancreatic stump to prevent post-operative pancreatic fistula following distal pancreatectomy.HPB (Oxford)2022
35616648Cancer Risk C (CR-C), a functional genomics test is a sensitive and rapid test for germline mismatch repair deficiency.Genet Med2022
35512400Genome-Wide Interaction Analysis of Genetic Variants With Menopausal Hormone Therapy for Colorectal Cancer Risk.J Natl Cancer Inst2022
35383926Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases.Int J Cancer2022
35353121Recipient and Donor Outcomes After Living-Donor Liver Transplant for Unresectable Colorectal Liver Metastases.JAMA Surg2022
35547873Intra-Tumoral CD8+ T-Cell Infiltration and PD-L1 Positivity in Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma.Front Oncol2022
35474005Is it safe to administer neoadjuvant chemotherapy to patients undergoing hepatectomy for intrahepatic cholangiocarcinoma? ACS-NSQIP propensity-matched analysis.HPB (Oxford)2022
35438744Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region.Cancer Epidemiol Biomarkers Prev2022
35668106Identifying colorectal cancer caused by biallelic MUTYH pathogenic variants using tumor mutational signatures.Nat Commun2022
35694787Correction: GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer.Clin Cancer Res2022
35715570Association between germline variants and somatic mutations in colorectal cancer.Sci Rep2022
35714671Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer?J Natl Compr Canc Netw2022
36591282Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU).Front Immunol2022
36533108Germline BRCA2 variants in advanced pancreatic acinar cell carcinoma: A case report and review of literature.World J Gastroenterol2022
  • 1 - 50 of 732

Recommended Authors

Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 5
Cumming School of Medicine, University of Calgary
Career Start Year 2008
Number of shared co-authors 6
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 8
Tisch Cancer Institute, Mount Sinai Hospital
Career Start Year 2005
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 12
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 10
University of Nebraska Medical Center
Career Start Year 2004
Number of shared co-authors 1
Goldman School of Medicine, Ben Gurion University
Career Start Year 2001
Number of shared co-authors 27
South Australian Health and Medical Research Institute
Career Start Year 2001
Number of shared co-authors 30
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 10
Dartmouth Hitchcock Medical Center
Career Start Year 1999
Number of shared co-authors 2
Uppsala University
Career Start Year 1999
Number of shared co-authors 6
University of California san francisco
Career Start Year 1999
Number of shared co-authors 6
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 25
The Icelandic Cancer Registry
Career Start Year 1997
Number of shared co-authors 1
Maastricht University Medical Center
Career Start Year 1996
Number of shared co-authors 3
Huntsman Cancer Institute
Career Start Year 1995
Number of shared co-authors 29
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 31
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 29
The Netherlands Cancer Institute
Career Start Year 1993
Number of shared co-authors 7
Georgetown University
Career Start Year 1993
Number of shared co-authors 5
University of California San Diego Moores Cancer Center
Career Start Year 1992
Number of shared co-authors 3
The Netherlands Cancer Institute
Career Start Year 1992
Number of shared co-authors 9
Nova Scotia Health Authority
Career Start Year 1992
Number of shared co-authors 4
Dartmouth-Hitchcock Medical Center
Career Start Year 1991
Number of shared co-authors 1
University of Pittsburgh
Career Start Year 1989
Number of shared co-authors 3
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1989
Number of shared co-authors 16
Oregon Health & Science University
Career Start Year 1985
Number of shared co-authors 9
University of California San Diego
Career Start Year 1985
Number of shared co-authors 11
Korea Advanced Institute of Science and Technology (KAIST)
Career Start Year 1982
Number of shared co-authors 2

Collaborators

Co-authored papers 145
Mayo Clinic
Co-authored papers 127
Mayo Clinic
Co-authored papers 96
Co-authored papers 94
Co-authored papers 88
Co-authored papers 85
Co-authored papers 75
German Cancer Research Center (DKFZ)
Co-authored papers 71
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 66
Mt Sinai Hospital
Co-authored papers 60
University of North Carolina at Chapel Hill
Co-authored papers 56
Mayo Clinic
Co-authored papers 56
National Cancer Institute, National Institutes of Health
Co-authored papers 50
Co-authored papers 48
Mount Sinai Hospital
Co-authored papers 47
Ontario Institute for Cancer Research
Co-authored papers 47
Co-authored papers 43
Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine
Co-authored papers 40
Ontario Institute for Cancer Research
Co-authored papers 39
Ontario Institute for Cancer Research
Co-authored papers 36
Harvard T.H. Chan School of Public Health
Co-authored papers 36
2Ontario Institute for Cancer Research
Co-authored papers 35
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 35
The Hospital for Sick Children
Co-authored papers 34
Ontario Institute for Cancer Research
Co-authored papers 34
Co-authored papers 33
University of Toronto
Co-authored papers 32
National Cancer Institute, 9609 Medical Center Dr
Co-authored papers 31
Co-authored papers 31
Co-authored papers 31